Drugs / Benzathine Penicillin
Benzathine Penicillin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03752112 | Nov 2019 → Mar 2021 | syphilis | World Health Organization | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07189208 | Sep 2025 → Dec 2029 expected | congenital syphilis | University of California, Los Angeles | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06707194 | Jun 2025 → Mar 2027 expected | ankylosing spondylitis | Nanfang Hospital, Southern Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT03637660 | Oct 2018 → Sep 2022 | syphilis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1 | NCT01310361 Comparator | Jan 2004 → Mar 2006 | streptococcal sore throat | Azad University of Medical Sciences | Completed | No outcome recorded |
| Phase 3 | NCT04958122 Comparator | Jun 2021 → Jan 2027 expected | HIV infectious disease, syphilis | University of Southern California | Recruiting | No outcome recorded |
| Phase 3 | NCT00031499 Comparator | Jun 2000 → Aug 2007 | syphilis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Met primary |
| Phase 4 | NCT07457385 Comparator | Nov 2026 → May 2031 expected | congenital syphilis | University of Alabama at Birmingham | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT02884115 Comparator | Aug 2016 → Sep 2020 | syphilis | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT07625228 Comparator | Jan 2027 → Dec 2030 expected | cardiac valvular defect, heart valve disorder, rheumatic fever | Ladoke Akintola University of Technology, Ogbomoso, Nigeria | Not yet recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Benzathine Penicillin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07457385 ↗ |
| Known as | Benzathin Penicillin G | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01310361 ↗ |
| Known as | benzathine penicillin G | “In this trial, the efficacy of azithromycin at a dosage of 2.0 g administered orally was equivalent to that of benzathine penicillin G for the treatment of early syphilis in...” PMID 20402591 ↗ Jun 20102“or benzathine penicillin G 2.4 million units intramuscularly based on the stage of syphilis infection” PMID 32522244 ↗ Jun 2020 “Benzathine Penicillin G (BPG) 2.4 MU” NCT03637660 ↗ |
| Known as | BPG | “the use of benzathine penicillin G (BPG) prophylaxis during pregnancy” NCT07189208 ↗1“Benzathine Penicillin G (BPG) 2.4 MU” NCT03637660 ↗ |
| Modality | Small molecule | “benzathine penicillin G 2.4 million units intramuscularly” PMID 32522244 ↗ Jun 2020 |
| Route | Intramuscular | “2.4 million units administered intramuscularly at Day 1, in one or both buttocks.” NCT00031499 ↗ |